RecruitingNCT05647109

Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer

Department of Obstetrics & Gynecology ,Peking University People's Hospital


Sponsor

Peking University People's Hospital

Enrollment

244 participants

Start Date

Sep 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

To construct a prediction model of progesterone sensitivity in patients with endometrial cancer treated with fertility preservation


Eligibility

Sex: FEMALEMin Age: 17 YearsMax Age: 45 Years

Inclusion Criteria4

  • Have a confirmed pathological diagnosis based upon hysteroscopy: atypical endometrial hyperplasia or histologically prove well-differentiated EEC G1 without myometrial invasion
  • No signs of suspicious extrauterine involvement on enhanced magnetic resonance imaging (MRI) or enhanced computed tomography (CT) or ultrasound
  • Have a desire for remaining reproductive function or uterus
  • Good compliance with adjunctive treatment and follow-up

Exclusion Criteria7

  • Acute liver disease or liver tumor (benign or malignant) or renal dysfunction
  • Pregnancy or potential pregnancy
  • Confirmed diagnosis of any cancer in reproductive system
  • Acute severe disease such as stroke or heart infarction or a history of thrombosis disease
  • Hypersensitivity or contradiction for using MPA or MA
  • With other factors of reproductive dysfunction;
  • Strong request for uterine removal or other conservative treatment

Interventions

OTHERNo intervention

No intervention


Locations(1)

Peking University People's Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05647109


Related Trials